DBI-EPIbreath®
Therapeutic Drug Monitoring
DevelopmentActive
Key Facts
About Deep Breath Intelligence
Deep Breath Intelligence is a Zurich-based diagnostics company pioneering the field of breath metabolomics. Its core platform integrates proprietary breath collection hardware (BreathCollector, BreathInjector) with a sophisticated analytical backend using SESI-HRMS and AI/ML to identify disease biomarkers. The company operates a hybrid business model, selling research-use products and offering fee-for-service contract research, while developing its first software-as-a-medical-device, DBI-EPIbreath®, for therapeutic drug monitoring. Positioned at the intersection of non-invasive diagnostics and personalized medicine, DBI targets both the research market and future clinical applications.
View full company profileOther Therapeutic Drug Monitoring Drugs
| Drug | Company | Phase |
|---|---|---|
| Platform Expansion - TDM | Intelligent Bio Solutions | Research |
| Abatacept (ORENCIA) ELISA Kit | Eagle Biosciences | Commercial |
| Adalimumab (HUMIRA) ELISA Kit | Eagle Biosciences | Commercial |
| Aflibercept (EYLEA) ELISA Kit | Eagle Biosciences | Commercial |